Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options

EVENT Summary

Dates

Saturday, April 27, 2024, 10:00 AM ET/9:00 AM CT

Location

Virtual

Target Audience

Ophthalmologists, optometrists, retina specialists, and advanced practice providers (physician assistants and nurse practitioners)

Format

Zoom Webinar

Credits

1.50 / AMA PRA Category 1 Credit(s)^TM
1.50 / COPE CE Credits

Cost

Free

Program Description

Click to Go to the Event Registration

The activity will focus on:

• Pathophysiology of Glaucoma – The balance between the secretion of aqueous humor by the ciliary body and its drainage through 2 independent pathways—the trabecular meshwork and uveoscleral outflow pathway—influences the IOP.

• Risk factors and Screening – Risk factors such as family history, ethnic origin, and age play an important role in screening. Screening of high-risk groups increased the positive predictive value of screening tests.

• Available Treatment Options for glaucoma – Treatment comprises topical agents, either as monotherapy or combination therapy.

• New Treatments to Improve Patient Outcomes – New sustained-release drug delivery systems in treating glaucoma.

• Inequities in Treating Glaucoma – The prevalence of glaucoma is high in African-American and Hispanic patients. Efforts should be placed to educate and train to expand better diagnostic and treatment options.

Agenda

• Overview of the risk factors, screening, current, and emerging therapies for glaucoma – David S. Friedman, MD, PhD, MPH
• Discuss inequities in the diagnosis and management of glaucoma in African-American and Hispanic populations – Karen Allison, MD, PC

Intended Audience

Ophthalmologists, optometrists, retina specialists, and advanced practice providers (physician assistants and nurse practitioners)

Commercial Supporter

Supported by an educational grant from Alcon Vision.

Learning Objectives

• Summarize the pathophysiology, risk factors, and screening of glaucoma
• Assess clinical trial data on topical agents in the management of glaucoma
• Appraise clinical trial data on sustained-release drug delivery systems in the management of glaucoma
• Analyze inequities in the diagnosis and management of glaucoma in African-American and Hispanic patients

Accredited Providers

Amedco and MedNet have collaborated to design and execute this activity.

   

Physicians (ACCME) Credit

Optometrists

Additional Credit Information

Physician Assistants
PAs may claim a maximum of 1.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit^TM from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. 1.5 hours.

Disclosures of Relationships with Ineligible Companies Policy

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24 months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify from involvement in the planning and implementation of accredited continuing education any individuals (1) who refuse to provide this information or (2) whose conflicts of interests cannot be mitigated.

Off-Label Disclosure Statement

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

Faculty

Karen Allison, MD, PC
Associate Professor of Clinical Ophthalmology
Department of Ophthalmology (SMD)
University of Rochester
Rochester, NY

David Friedman, MD, PhD, MPH
Ophthalmologist
Director, Glaucoma Service
Albert and Diane Kaneb Chair in Ophthalmology
Medical Director for Clinical Research at Mass. Eye and Ear
Boston, MA

Instructions/Technical Requirements

• A desktop or laptop computer or a mobile device with a stable internet connection and audio capability is required to attend. Joining via mobile or tablet is possible but not recommended.
• Times in the portal adjust to your computer; however, some browsers have a separate time zone adjustment.
• For the best viewing experience, we recommend the following browsers: Chrome, Firefox, and Safari. For attendees viewing on Internet Explorer 11, you may experience lags in streaming. To maximize your attendee hub experience, we recommend you not sign in through your company assigned VPN.
• Ensure that your computer’s sound is enabled for your browser and allow permissions to the On24 Attendee Hub platform if necessary.

Cost

Complimentary

Contact

Brian Waggoner
Program Manager
MedNet
brianw@mmhus.net